Search

everythinglearnresearchcommunity

for

Search:↓

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Sex hormones affect brain injury differently in males and females.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Oral bicalutamide is safe and effective for female hair loss.

Young adults with hair loss face higher risk of stiff arteries.

Baldness may be linked to heart disease, but the evidence isn't strong enough to consider it a major risk factor.

Dermatologists helped identify COVID-19 through skin symptoms and managed skin issues during the pandemic, but more high-quality research is needed.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Adult offspring of sperm donation generally feel positive about their conception and view the donor as their biological father.

Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

More research is needed to understand sex and racial differences in long COVID.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.